Recipient interferon-γ 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Haematologica

Volumn 90, Issue 3, 2005, Pages 425-426

  Bogunia Kubik, Katarzyna ^a   Mlynarczewska, Anna ^a   Wysoczanska, Barbara ^a   Lange, Andrzej ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b Bone Marrow Donor Registry   (Poland)

Author keywords

(CA)n microsatellite; Allogeneic hematopoitic stem cell transplantation; Chronic GvHD; IFN production; IFN gene polymorphism

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; LOGISTIC REGRESSION ANALYSIS; MALE; RISK;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYCLOSPORINE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INTERFERON TYPE II; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 15244359593     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9:215-33.
2. Higman MA, Vogelsang GB. Chronic graft versus host disease. Br J Haematol 2004;125:435-54.
3. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-8.
4. Socié G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, et al. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation 2001;72:699-706.
5. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001;98:1594-600.
6. Takahashi H, Furukawa T, Hashimoto S, Suzuki N, Kuroha T, Yamazaki F, et al. Contribution of TNF-α and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 2000;26:1317-23.
7. Lange A, Bogunia-Kubik K, Karabon L, Polak M. An evidence that while differences in polymorphism in TNF-β and IL-6 genes are associated with toxic complications after bone marrow transplantation, differences in polymorphism in IFN-γ gene with a higher risk of GvHD. Blood 2000;96:398a [abstract 1716].
8. Mlynarczewska A, Wysoczanska B, Karabon L, Bogunia-Kubik K, Lange A. Lack of IFN-γ 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGvHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation. Bone Marrow Transplant 2004;34:339-44.
9. Pravica V, Asderakis A, Perrey C, Hajer A, Sinnott PJ, Hutchinson IV. In vitro production of interferon-γ correlates with CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogenet 1999;26:1-3.
10. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.